Investing News NetworkYour trusted source for investing success

cancer genetics

Cancer Genetics Reports Q3 Financial Results

Cancer Genetics Reports Q2 Financial Results

Cancer Genetics Announces Pricing of $3.5 Million Public Offering of Common Stock

Cancer Genetics Terminates Proposed Merger with NovellusDx

Cancer Genetics and Genecast Partner on Gene Test

Cancer Genetics Enters Strategic Partnership with Genecast Biotechnology to Commercialize Tissue of Origin Test in China

VIDEO - Life Science Update September 2018

Cancer Genetics Merges with NovellusDx

Cancer Genetics and NovellusDx Sign Definitive Agreement to Merge

Cancer Genetics Closes $2.625 million Convertible Note Financing

C29 Metals shifts focus to Mayfield Copper Project

Equity Metals: Advancing High-grade, District-scale Silver and Gold Assets in British Columbia

South Harz Potash: A Globally Significant European Potash and Critical Minerals Opportunity

Ian Rodger Appointed Managing Director

Terra Clean Energy: Advancing an Expansive Uranium Landholding in the Prolific Athabasca Basin

South Harz Potash Limited

Equity Metals

Terra Clean Energy

BP

NevGold

FinEx Metals

MARKETS

COMMODITIES

CURRENCIES